Podcasts about Cervical cancer

In this episode of GynoCurious, host Dr. Amy Novatt welcomes Dr. Miriam Cremer, board-certified OBGYN, master of public health, and founder of Basic Health International, for a deep dive into cervical cancer. Together they unpack the science of human papillomavirus (HPV), explaining how 13 high-risk HPV types cause 99% of all cervical cancers and why HPV is so ubiquitous that it's often compared to the common cold. They walk through the evolution of cervical cancer screening, from the classic Pap smear to co-testing with HPV, and discuss how primary HPV testing — already standard across Europe — is likely the future of care in the United States. Dr. Cremer shares the origin story of Basic Health International, which grew from a formative medical school rotation in rural El Salvador where she witnessed a young mother die from cervical cancer — a death that was entirely preventable. The conversation covers cutting-edge developments in screening and treatment, including HPV self-sampling kits, AI-assisted cervical imaging apps, and portable thermal ablation devices that can be carried in a backpack and used in remote communities. These innovations are enabling same-day "screen and treat" programs that are reaching women in underserved regions across Latin America and beyond, including a now-national HPV screening program in El Salvador. They also cover patient fears and misconceptions head-on — from the stigma of an HPV diagnosis to questions about condom protection, the HPV vaccine (including catch-up vaccination up to age 45), and when screening can safely stop. Dr. Cremer and Dr. Novatt emphasize that cervical cancer is almost entirely preventable, and that the women most at risk today are those who have fallen through the cracks of healthcare access — not those who are regularly screened. Questions of comments? Call 845-307-7446 or email comments@radiofreerhinecliff.org Produced by Jennifer Hammoud and Matty Rosenberg @ Radio Free Rhiniecliff

What if the reason your cells are breaking down isn't a mystery - it's simply a lack of oxygen? In this episode of Integrative Cancer Solutions, Dr. K sits down with Teresa Reile, cancer survivor, hypoxia specialist, and founder of Patriox Health Freedom, to share a story that goes far beyond a diagnosis. After surviving cervical cancer in 2012 while managing 48 companies and going through a divorce, Teresa discovered a decade later that the cancer had returned - silently. What she found in Hungary, a drinkable and bathable oxygen technology developed over 25 years, cleared her scan results in under three weeks. Now she's brought that technology to the United States. This conversation covers the real root cause most doctors never test for, why cellular hypoxia underlies nearly every chronic condition, how the HIF-1 alpha test can detect it before disease takes hold, and why oxygen may be the most overlooked nutrient in modern medicine. Key Takeaways: 0:00 Introduction  1:27 Running 48 companies, a divorce, and a cancer diagnosis  3:20 Getting the news and still making it to the wedding  5:08 What the medical system got wrong after surgery 10:28 When cancer came back a decade later  13:42 Cellular hypoxia and how it starts the disease process  28:23 Why cancer hates oxygen and what that means for treatment 37:30 Words of wisdom for high-achieving entrepreneurs  Schedule a Free 15-Min Cancer/Lyme Consultation at The Karlfeldt Center: 208-338-8902 Resources: Patriox Health Freedom — https://patriox.us/ Medical Disclaimer: This content is for educational purposes only and is not intended to diagnose, treat, cure, or replace professional medical advice. Always consult your physician or qualified healthcare provider regarding any medical condition or treatment decisions. ____________________________________RESOURCES FROM DR. KARLFELDT:

Despite cervical cancer being nearly 100% preventable through routine screening, almost one in three U.S. women are behind, and the numbers have been moving in the wrong direction for a decade. Kara Egan, CEO and Co-Founder of Teal Health, left a career as a health tech investor to fix one of the most overlooked gaps in women's preventive care. In May 2025, Teal received the only FDA authorization for at-home cervical cancer screening, and just seven months later had scaled to all 50 states. In this conversation, Kara breaks down what it actually takes to redesign a screening process that hasn't meaningfully changed in 80 years, how regulatory alignment and updated clinical guidelines are reshaping the landscape, and what at-home diagnostics signal for the future of preventive care and women's health access broadly. Kara Egan, CEO and Co-Founder, Teal Health Megan Antonelli, CEO, HealthIMPACT Live

1 in 3 Women Unscreened On Closing the Cervical Cancer Gap Despite cervical cancer being nearly 100% preventable through routine screening, almost one in three U.S. women are behind, and the numbers have been moving in the wrong direction for a decade. Kara Egan, CEO and Co-Founder of Teal Health, left a career as a health tech investor to fix one of the most overlooked gaps in women's preventive care. In May 2025, Teal received the only FDA authorization for at-home cervical cancer screening, and just seven months later had scaled to all 50 states. In this conversation, Kara breaks down what it actually takes to redesign a screening process that hasn't meaningfully changed in 80 years, how regulatory alignment and updated clinical guidelines are reshaping the landscape, and what at-home diagnostics signal for the future of preventive care and women's health access broadly. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Ericka shares her personal journey from repeated ER visits to diagnosis and coordinated multidisciplinary care at Riverside Cancer Institute. A hopeful, honest account of radiation therapy, chemotherapy, brachytherapy, and ongoing immunotherapy — and the staff, family, and community supports that made the difference.

From Discovery to Delivery: Charting Progress in Gynecologic Oncology, hosted by Ursula A. Matulonis, MD, brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers. Dr Matulonis is chief of the Division of Gynecologic Oncology and the Brock-Wilson Family Chair at the Dana-Farber Cancer Institute, as well as a professor of medicine at Harvard Medical School, both in Boston, Massachusetts.In this episode, Dr Matulonis was joined by Meghan E. Shea, MD, an attending medical oncologist and ambulatory medical director and disease program leader for medical oncology at Beth Israel Deaconess Medical Center in Boston. Together, they explored the current landscape of cervical cancer, from the urgent need for expanded vaccination and screening to the evolving role of immunotherapy and antibody-drug conjugates (ADCs) across disease settings.Dr Shea opened by addressing the epidemiology of cervical cancer, noting that despite decades of progress, rates are now plateauing and rising among women under 50 years of age. She identified 3 interrelated drivers of this trend: declining rates of routine gynecologic screening, inconsistent uptake of human papillomavirus (HPV) vaccination, and persistent high-risk HPV infections, particularly HPV 16 and 18, which are responsible for most cases. The conversation then turned to the effect of immunotherapy on cervical cancer treatment. Dr Shea traced the evolution of pembrolizumab (Keytruda) from its initial 2018 approval as a single agent in recurrent/metastatic disease to its more recent integration into the frontline setting. The phase 3 KEYNOTE-A18 trial (NCT04221945) demonstrated that adding pembrolizumab to standard weekly cisplatin-based chemoradiation significantly improved outcomes for patients with locally advanced disease. Although responses to immunotherapy, when they occur, are often durable, Dr Shea acknowledged that response rates remain lower than anticipated for a virally driven malignancy, underscoring the need for novel combinations and a deeper understanding of resistance mechanisms. Drs Matulonis and Shea both agreed that immunotherapy combined with ADCs represents one of the most compelling directions for the field, with phase 2 data for sacituzumab tirumotecan plus pembrolizumab generating interest ahead of anticipated phase 3 results.On the ADC front, Dr Shea reviewed the 2 agents in this class that are currently FDA-approved for cervical cancer. Tisotumab vedotin-tftv (Tivdak) offers the advantage of biomarker-independent use, though its requirement for ophthalmologic monitoring at every treatment visit creates real-world access challenges outside major academic centers. Trastuzumab deruxtecan-nxki (Enhertu), approved in the HER2 immunohistochemistry 3+ setting based in part on the results of the phase 2 DESTINY-PanTumor02 trial (NCT04482309), has generated robust response rates but is most likely to benefit patients with adenocarcinoma. Dr Shea also highlighted additional targets under investigation, including Trop-2, Nectin-4, and B7-H4, with multiple phase 3 trials ongoing in both the frontline and recurrent settings.The discussion closed with a look at the locally advanced disease landscape, where the NRG Oncology cooperative group is conducting a phase 3 trial to evaluate whether integrating the neoadjuvant carboplatin/paclitaxel regimen from the INTERLACE trial (NCT01566240) with the pembrolizumab-based regimen from KEYNOTE-A18 can further improve outcomes and reduce the morbidity associated with brachytherapy. Dr Shea expressed optimism about this question, citing preliminary experience suggesting that neoadjuvant chemotherapy may reduce the need for invasive radiation techniques.

Rachel McElreath is 28 years old, graduated from the 5x Certification, and has already lived more lives than most people do in a lifetime. She started drinking at 15, Halloween night in Atlanta, a bottle of Hennessy handed to her by a friend, parents in crisis at home, and spent the next decade building a life that looked fine from the outside and was quietly falling apart underneath. She held jobs, went to college, went to beauty school.  She also worked bottle service in Dallas, dated men who weren't available, and kept ignoring an inner voice that was getting louder by the year. The thing that finally made her stop wasn't a gradual awakening. It was a phone call from her doctor in late 2023 telling her she was one stage away from cervical cancer. That week, she left the relationship she was in. A few weeks later, she quit drinking and made the decision to be celibate, both at the same time. She spent 2024 meeting herself for the first time, rebuilding from almost nothing, and figuring out who she actually was without alcohol, without men, and without the nightlife identity she had built her entire social world around. Now she coaches women through that same process, not just getting sober, but building a life they're actually excited to wake up to. This conversation goes places a lot of podcast episodes don't. We talk about HPV and cervical cancer, three abortions in one year, sexual assault, trauma bonding, and what it actually feels like to realize that the shame you've been carrying isn't yours to keep. Rachel shares all of it without flinching, and that's exactly what makes her work so powerful.   IN THIS EPISODE: Starting to drink at 15 when home didn't feel safe, and how that one decision shaped the next decade Working bottle service while her body was sending her signals she kept overriding The phone call from her doctor and what she decided in the weeks that followed Why she quit alcohol and went celibate at the same time, and what two and a half years of that has actually been like The loneliness of dissolving an entire identity and why 2024 was somehow still the best year of her life What she sees shifting in the younger generation around alcohol, and why she's genuinely excited about it   LINKS/RESOURCES MENTIONED Follow Rachel on Instagram.  Euphoric the Club is the premier space to lose the desire for alcohol as you surround yourself with successful women who don't drink (and the women who are becoming them). Euphoric the Club includes full access to all of my alcohol-free programs to make alcohol meaningless as your dreams take center stage.  If you know you're meant to help other people change their relationship with alcohol and create a profitable online brand, be sure to get on the waitlist for the Empowered AF Coach 5x Certification – and get 5x certified as a world class alcohol-free empowerment coach, subconscious change coach, success coach, NLP practitioner, and hypnosis practitioner and implement our 0 to $100k Coach Method™ as your build a profitable brand.  Profiling successful people who don't drink and where the alcohol-free lifestyle and entrepreneurship collide. Subscribe to the Euphoric AF YouTube channel. Join over 20,000 souls who tune into weekly newsletters on the competitive advantage you get alcohol-free. Get on the Euphoric newsletter. Read Euphoric: my HarperCollins bestseller on losing the desire for alcohol while getting high on your dream life. Be sure to get your copy of Euphoric: Ditch Alcohol and Gain a Happier, More Confident You today or grab your free chapter here.  Apply to be our next Thought Leader to master premium selling and thought leader positioning to publish your book and deliver your keynote onstage.  Follow @euphoric.af on Instagram.  And as always, rate, review, and subscribe so we can continue spreading our message far and wide.

Cervical cancer is the fourth most common cancer in women globally, but it's also highly preventable. Rotarian, surgical oncologist, and author Dr. Richard Godfrey has traveled the world making cervical cancer prevention more accessible. His forthcoming book, Medical Moonshots: Winning the Cancer War, talks about his lifesaving work. Niala Boodhoo recently sat down with Dr. Godfrey to discuss his career, cervical cancer, and Rotary's work to eliminate it.

The World Health Organisation has set an ambitious goal to eliminate cervical cancer. New Zealand health experts are optimistic we can do it, but suggest there are challenges to achieving that aim.Sign up to the Our Changing World monthly newsletter for episode backstories, science analysis and more.Learn more:Listen to The Panel Plus with Wallace Chapman, discussing the release of the Cancer Society's election manifesto and treatment options for cancer.Read about the Matariki Fund's plans to eliminate cervical cancer across the Pacific.RNZ's Māori issues reporter Pokere Paewai wrote this article on the need to extend free cervical screening.The efficacy of the HPV vaccine was discussed on Morning Report, following a study which showed a 60% reduction in cervical cancer.Guests:Professor Bev Lawton (Ngāti Porou), is founder/director of Te Tātai Hauora o Hine (the National Centre for Women's Health Research Aotearoa) at Victoria University of WellingtonNicola Coom, Chief Executive of the Cancer SocietyAlice Hyatt, cancer survivorGo to this episode on rnz.co.nz for more details

Being uninsured, speaking a different language, or not understanding a 40-page form should never decide who lives or dies. In this episode, patient navigators Laura Tovar and Elizabeth Esparza walk us through what really happens after an uninsured woman hears “you have breast cancer” at The Rose. They explain how they review applications before diagnosis, sit in the room with the radiologist, and answer the first question they always hear: “How am I going to pay for this?” They also talk about the maze behind assistance programs for uninsured patients, what it takes to keep coverage from lapsing in the middle of chemo, and the impossible choices some families face during their breast cancer journey. Along the way, Laura and Elizabeth share what it costs them emotionally to carry these stories, why they sometimes cry with husbands and children, and how quilts, gas cards, summer camps, and rent assistance become part of making sure no woman has to face breast cancer or the paperwork alone. Support The Rose HERE. Subscribe to Let’s Talk About Your Breasts on Apple Podcasts, Spotify, iHeart, and wherever you get your podcasts. Key Questions Answered 1. What does “patient navigation to treatment” mean at The Rose, and how is it different from scheduling or basic navigation? 2. How do Laura and Elizabeth first learn about a woman, and what happens between her initial mammogram and a positive diagnosis? 3. What are the main treatment access programs for uninsured women in this episode (Harris Health/Gold Card and Medicaid for Breast and Cervical Cancer)? 4. Who qualifies for Medicaid for Breast and Cervical Cancer, and how do income, age, citizenship, and “working quarters” factor in? 5. Why do many newly diagnosed women worry more about cost and payment than about the cancer itself? 6. How do navigators match patients with facilities and oncology practices that actually accept their specific Medicaid HMO plan? 7. What happens when Medicaid coverage lapses during chemo, and how do Laura and Elizabeth intervene to get treatment restarted? 8. How do they explain a breast cancer diagnosis differently to small children, teenagers, and spouses, and why are husbands often the most visibly shaken? 9. What are some of the hardest situations they see, including women moving counties or divorcing to meet eligibility rules, or being asked for large deposits to start chemo? 10. How do Laura and Elizabeth support patients with complex applications, missing documents, language barriers, and repeated denials from eligibility offices? 11. What other practical resources do they connect families to, such as food assistance, utility and rent support, camps for kids, gas cards, wigs, bras, and comfort items? 12. How do they cope with the emotional toll of this work while trying to remain steady for patients and their families? Timestamped Overview 00:00 Dorothy opens with how insurance status, language, and paperwork can determine who lives or dies, and introduces patient navigators Laura Tovar and Elizabeth Esparza.01:45 Laura and Elizabeth share how long they have been at The Rose and the roles they held before moving into patient navigation to treatment.02:35 Dorothy explains “sponsorship” as intake for assistance programs and why The Rose avoids the word “charity.”03:10 Elizabeth defines patient navigation to treatment as helping mostly uninsured, newly diagnosed women find a path into actual cancer care.03:50 Elizabeth describes reviewing applications a day or two before diagnosis to anticipate which treatment program might fit.04:25 Laura walks through what happens on the day a woman learns she has breast cancer and how navigators stay with her after the radiologist leaves.05:30 Elizabeth outlines key treatment programs: Harris Health (Gold Card) for county residents and Medicaid for Breast and Cervical Cancer (MBCC).06:00 Laura and Elizabeth explain MBCC eligibility, including age limits, income guidelines, citizenship, legal residency, five-year residency rules, and working quarters.08:20 They describe the questions women ask first after diagnosis, centered on cost, payment, and whether existing coverage at The Rose will extend to treatment.09:20 Laura explains why The Rose refers many MBCC patients to Texas Oncology and how they choose facilities that accept specific Medicaid HMO plans.10:30 They discuss how confusing HMO choices and insurance concepts are for women who have never had coverage and fear they will have to “pay it back.”11:20 Dorothy notes that many major cancer hospitals do not accept these plans, increasing reliance on a smaller network of providers.12:00 Laura and Elizabeth talk about the need to renew Medicaid every 12 months, how patients can forget during treatment, and what happens when coverage expires mid-chemo.12:35 They describe calling Medicaid, troubleshooting reasons for termination, and sometimes getting coverage reinstated within days.13:40 Dorothy asks how much information patients actually absorb at diagnosis; Laura and Elizabeth estimate many do not hear most of what is said.14:10 Laura explains follow-up calls, longer consultations, and sometimes separate visits to help spouses and children understand the diagnosis and plan.15:10 They share that husbands often cry more than patients because they feel helpless and unable to “fix” the situation or pay for care.16:30 Elizabeth describes how they tailor explanations for children by age, avoiding the word “cancer” with very young kids and framing treatment as strong medicine.17:10 They talk about the emotional toll of this work, the difficulty of holding in tears, and moments when they cry alongside patients.18:20 Dorothy raises the growing number of women who do not meet changing criteria for key programs and need entirely different solutions.18:55 Elizabeth describes families uprooting their lives to move into Harris County so they can qualify for Harris Health coverage.19:40 Dorothy notes some women feel forced to divorce to reduce household income enough to meet eligibility rules.20:20 They mention stopgap strategies like GoFundMe campaigns, cash-pay arrangements, and sliding-scale clinics that still remain expensive for women living paycheck to paycheck.21:20 Laura and Elizabeth share examples of women being asked for large deposits, including a $15,000 payment to begin chemotherapy.22:10 They discuss the complexity and length of application packets like the Harris Health form and why careful completion matters.22:40 Laura explains how nerves cause patients to make simple errors—wrong dates, missing boxes—that delay approval for months.23:30 They describe helping women who were diagnosed elsewhere but come to The Rose for help with Gold Card or other eligibility obstacles.24:10 Laura outlines how they review documents, join three-way calls with agencies, and clarify what paperwork is actually missing.24:50 Elizabeth explains why they personally deliver applications to eligibility centers instead of relying on patients who lack transportation or time.25:35 Dorothy reflects on her earlier belief that a diagnosis and pathology report would be enough, and how language and bureaucracy proved otherwise.26:20 She recalls that the realization of repeated denials and confusion led directly to creating the Patient Navigation to Treatment program.27:15 Elizabeth shares work with Rice University and Camp Kesem to connect children of cancer patients with supportive summer programs.28:10 Laura and Elizabeth list other resources they connect families to, including food banks, rent and utility help, medication support, gas cards, wigs, bras, prostheses, and comfort bags.29:20 Dorothy highlights the impact of donated quilts, heart pillows, and small items that remind women someone cares about them.30:00 Laura and Elizabeth admit that the work is overwhelming at times, especially when they cannot find a path to treatment for a particular woman.30:30 Dorothy closes by emphasizing that, for most uninsured patients, Laura and Elizabeth are the bridge to treatment and invites listeners to recognize and support this work.See omnystudio.com/listener for privacy information.

In 2023, New Zealand made a very important switch, moving from traditional cervical screenings to HPV screenings. Since then, cervical screening rates have increased significantly – particularly as a result of self-screening. What is HPV screening? 170 cases of cervical cancer are diagnosed per year, but there are only 50 deaths per year – it's preventable HPV screening tests are for ‘Human papillomavirus', the virus that causes almost all cervical cancers It has replaced the traditional smear (cytology) test in cervical screening program It's recommended for women aged 25–69, every five years if the HPV test is negative It's a simple self-test vaginal swab If HPV is detected, further testing such as a cervical smear or there will be a referral straight to specialist Why HPV screening is better than traditional cervical screening? It detects the cause, not just the changes. The old smear test looked for abnormal cells, while the HPV test detects the virus that causes the changes that lead to cervical cancer This means the earlier identification of risk HPV testing is significantly more accurate at detecting the risk of cervical cancer – fewer cases are missed compared to cytology It's safe to screen every five years instead of three What are the other advantages? It reduces barriers to testing; it's less invasive, less embarrassing, and there's less discomfort More women are taking up screening as result International evidence shows HPV screening detects more pre-cancer earlier and leads to greater reductions in cervical cancer rates The take home message? HPV screening is a more accurate, earlier, and more effective way to prevent cervical cancer It allows longer intervals, self-testing, and better access It's a major step forward from traditional smear-based programmes See your doctor or nurse to talk about it LISTEN ABOVE See omnystudio.com/listener for privacy information.

John Maytham speaks to Hennie Botha about the global push to eliminate cervical cancer, the role of HPV vaccines and screening, and whether South Africa could see a broader rollout or expansion of similar prevention programmes. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

HPV gets treated like a life sentence, and the conversation usually stops at fear, procedures, or a vaccine that does not fully protect. In this episode, Dr. Ritamarie talks with women's health expert Dr. Doni Wilson about what actually drives HPV persistence, why most women are told “there's nothing you can do,” and how a terrain-based approach helps the body clear high-risk HPV and stay negative long term.You'll learn what to look for beyond exposure, how the vaginal microbiome, hormones, blood sugar, nutrient status, toxins, and chronic stress shape susceptibility, and which overlooked lab clues can point to the real problem, before it becomes a crisis.What's Inside This Episode?The question most HPV conversations never askWhy eliminating a virus isn't the same as eliminating riskThe early signals and lab clues that matter before abnormal cells appearThe missing piece in cervical cancer prevention most women never hearHow understanding the why changes everythingResources and Links:Download the full transcript here. Download our FREE Free Guide to Supporting a Healthy and Balanced Immune SystemJoin the Next-Level Health Practitioner Facebook group here for free resources and community supportVisit INEMethod.com for advanced health practitioner training and tools to elevate your clinical skills and grow your practice by getting life-changing results. Check out other podcast episodes hereGuest Resources and Links Dr. Doni Wilson's website: doctordoni.com Get Dr Doni's Free Training for Healthcare PractitionersFind Dr Doni on Facebook: @drdoniwilsonInstagram: @drdoniwilsonTwitter: @glutenfreedocTickTok: @drdoniwildonYoutube: https://www.youtube.com/@DoniWilsonNDGuest BioDr. Doni Wilson is a powerhouse naturopathic doctor, professional midwife, clinical nutritionist, best-selling author of Master Your Stress, Reset Your Health, and an internationally renowned speaker and thought leader in women's health. For over 25 years, she has been on the cutting edge of health care, helping women to transform their health naturally. As the creator of the Stress Recovery Protocol®, developed through her own journey overcoming chronic migraines, Dr. Doni has helped thousands of patients break free from health challenges and become resilient to stress. A true advocate for women's health, she is dedicated to empowering others to take control of their healing, drawing awareness to the profound impact of stress and trauma on the body.You can find her blog, podcast How Humans Heal, and transformational programs at DoctorDoni.com.

LSU Health New Orleans has a plan to try and eliminate cervical cancer in Louisiana. We talk about how serious the problem is and the Bayou Blueprint to beat it with Dr. Donna Williams, Professor and Associate Dean for Public Health Practice and Community Engagement at LSU Health New Orleans

* Governor Landry blasted the criminal justice system for being soft on juvenile crime. We'll check in with Rafael Goyeneche, the president of the Metropolitan Crime Commission, for what he's seeing from the juvenile justice system. * LSU Health New Orleans has a plan to try and eliminate cervical cancer in Louisiana. We'll talk about how serious the problem is and the Bayou Blueprint to beat it with Dr. Donna Williams.

When it comes to cancer, risk does not mean destiny—and understanding the facts can make all the difference.In this episode of Baptist HealthTalk, Dr. Anthony Gonzalez is joined by Dr. Justin Dubin, Director of Men's Sexual Health at Baptist Health Miami Cancer Institute, and Dr. Ryan Matthew Kahn, Gynecologic Oncologist with Baptist Health Cancer Care.Together, they break down the real connection between cancer, hormones, and HPV—separating myths from medical facts and highlighting what you can actually do to reduce your risk.You'll learn: The most common cancers affecting men and women—and how to catch them early  Updated screening guidelines, including changes to prostate cancer testing  How hormones can influence cancer risk, treatment, and recovery  The truth about testosterone and prostate cancer  What HPV does in both women and men—including its link to throat cancer  Why the HPV vaccine is important for all genders (and not just teens)  Simple, actionable steps you can take today to support prevention Whether you're thinking about your own health or looking out for your family, this episode offers clear, practical guidance to help you stay informed and proactive.Host:Anthony Gonzalez, M.D.Chief of Surgery, Baptist Health Baptist HospitalMedical Director of Bariatric Surgery, Baptist HealthGuests:Justin Dubin, M.D.Director of Men's Sexual HealthBaptist Health Miami Cancer InstituteRyan Matthew Kahn, M.D.Gynecologic OncologistBaptist Health Cancer CareIf you found this episode helpful, you may also enjoy:Can Cervical Cancer Be Cured? A Gynecologic Oncologist AnswerErectile Dysfunction, Low Testosterone & Fertility ExplainedHPV-Related Cancers

Send us Fan MailDeep Learning Can Predict the Overall Survival of Cervical Cancer Based on Histopathological Image, Gene Mutation and Clinical Information. Shen J, Miao Z, Wang L, et al. IET Systems Biology 2026.Episode Summary: In this deep dive, we explore a groundbreaking 2026 study that uses multimodal deep learning to act as a "master diagnostician" for cervical cancer. We examine what happens when an AI is fed a combination of standard clinical data, cutting-edge genetic sequencing, and century-old H&E tissue slides. The results force us to rethink how cancer operates: what happens when the genetic "blueprint" of a tumor lies to us, and the real biological truth is hiding in the seemingly chaotic pink and purple pixels of the connective tissue?In This Episode, We Cover:The Murky Diagnostics of Oncology: Understanding why predicting an individual patient's overall survival (OS) in cervical cancer is profoundly difficult. Getting this prediction wrong means risking either lethal undertreatment (distant metastasis) or subjecting stable patients to devastating overtreatment toxicities.The Three Modalities (The Suspect, The DNA, and The Security Footage):Clinical Data: The "suspect's description," utilizing standard patient metrics like age and tumor stage.Molecular Data: The genetic "blueprint" and somatic gene mutations. The AI isolated major red flags like RGR, DBN1, and CALCR mutations, which drive metastasis and signal poor prognosis.Histopathological Images (H&E): The "security footage" showing the physical tissue battlefield via whole slide images.The Model Showdown: Researchers trained a deep learning model (ResNet18) and fused these modalities using Multimodal Compact Bilinear (MCB) fusion. The AI was tasked with classifying patients into short-term (under 3 years) or long-term (over 3 years) survival, and it was rigorously validated on a completely independent dataset (PUMCH) to ensure generalizability.Round 1 - The Genetic Curveball: Despite being the cell's source code, genetic mutation data was the absolute worst predictor of survival, achieving an AUC of just 0.559. Adding it to the AI actually caused the "curse of dimensionality," making the model worse by overwhelming it with mathematical noise.Round 2 - The AI's "Aha!" Moment: The tissue phenotype dictates what actually happens. Fusing simple clinical data (age) with H&E images achieved a highly accurate 0.783 AUC. Even more shockingly, for aggressive short-term survival cases, the AI didn't focus heavily on the tumor itself. It looked at the stroma (connective tissue), deducing on its own that the host's inflammatory battleground dictates the lethality of the disease.The Future of the Lab: How automated quality control (HistoQC) and mathematical techniques (Macenko color normalization) strip away lab technician error and chemical dye variations. We also look ahead to how hyperspectral imaging might soon reveal the foundational chemical signatures of living cells.Key Takeaway: Throwing more data at an algorithm isn't always better. By successfully extracting profound biological truths from routine, inexpensive H&E slides, the AI proved that we don't necessarily need $1,000 genomic sequencing panels to accurately predict prognosis. The physical manifestation of the tumor microenvironment tells us exactly who is winning the battle, paving the way for accessible precision medicineSupport the showGet the "Digital Pathology 101" FREE E-book and join us!

Cervical cancer is largely preventable, but gaps in screening, stigma and access to care continue to leave many women at risk, a University of Washington physician says.

She spent 15 years with a DL man, got HPV that turned into cervical cancer, and now he's expecting a baby with a 25 year old. Should she tell her?The aunties are back and this one came out swinging. This week's listener letter has us deep in the ethics of DL men, the danger of staying silent, and what you actually owe women who don't know what you know. Then we shift into enemies of progress mode Jack Harlow calling his album "blacker," Charlamagne and Andrew Schulz's Oscar joke landing wrong, Louis Theroux letting the manosphere off too easy, and Belgium finally putting a 93 year old on trial for Patrice Lumumba's murder. Oh and we also need to talk about meningitis, Cuba, and what happens when all your exes end up in the same room.⚡ DL men, HPV & cervical cancer should she warn the new girlfriend? ⚡ Jack Harlow says his album is "blacker" we are not okay ⚡ Charlamagne & Andrew Schulz's N-word Oscar joke: funny or enemy activity? ⚡ Louis Theroux's manosphere doc why did he let them off so light? ⚡ Patrice Lumumba, Belgium & the 93 year old diplomat finally facing trial ⚡ Meningitis outbreak how it shows up on dark skin & what to watch for ⚡ Cuba, Trump & a blockade that is actively killing people ⚡ What would you do if all your exes were in your living room?This is the podcast for Black women who are done pretending everything is fine.

In today's webinar, Tom discussed if HPV causes cervical cancer.Check out Mike Stone's (ViroLIEgy) HPV article here: https://viroliegy.com/category/hpv/Other items discussed:The link to Tom's new book “Commonsense Childrearing: Unconventional Wisdom for a Nourished Childhood”  can be found here: https://amzn.to/3VWT1e7We are doing a special webinar this Saturday, January 18th, 2025 at 12 PM ET; we hope you can join us!Join Tom & our wellness specialists at the New Biology Clinic for a public webinar - the discussion will center around common sense parenting & Tom's new book.Register here: https://bit.ly/4gSIqJGDr. Cowan's Garden released 2 new products this week. Organic Balsamic Vinegar & Organic Olive Paste- If you are interested in checking these out, the links are here:https://www.drcowansgarden.com/collections/olive-pastehttps://www.drcowansgarden.com/products/organic-balsamic-vinegarSupport the showWebsites:https://drtomcowan.com/https://www.drcowansgarden.com/https://newbiologyclinic.com/https://newbiologycurriculum.com/Instagram: @TalkinTurkeywithTomFacebook: https://www.facebook.com/DrTomCowan/Bitchute: https://www.bitchute.com/channel/CivTSuEjw6Qp/YouTube: https://www.youtube.com/channel/UCzxdc2o0Q_XZIPwo07XCrNg

Jersey Shore star Snooki has shared her stage 1 cervical cancer diagnosis, and it sets the tone for a powerful conversation on this week's Dr. Frita LIVE! We break down what stage 1 really means in everyday language and why that routine Pap smear she almost skipped may have saved her life.We also talk about the BAFTAs Tourette's outburst that sparked confusion online. What is Tourette syndrome, and why do involuntary vocal tics happen? We explain the brain science in simple terms and clear up the myths around coprolalia so people understand the difference between a symptom and intent.We're holding Mary Cosby and her family in our thoughts and prayers after the heartbreaking loss of her son. His struggle with addiction recovery reminds us that 30-day programs are often just the first step. We discuss what relapse actually means medically and how families can offer support without burning out.Then there's Former NBA Star Chris Bosh, who recently described a terrifying collapse years after blood clots ended his career. We'll separate myth from fact about fainting and sudden blackouts.Finally, we'll get to the bottom of what the Surgeon General nominee said about childhood vaccines and why those comments matter to parents trying to make informed decisions in the middle of measles outbreak headlines.Behind every headline is a family living through it. Grief is real. Addiction is real. And honest conversations like this can help someone feel seen instead of alone.#HealthHappyLifePodcast #DrFrita #DrFritaLIVE! #CelebrityHealthNewsHere are a few helpful resources to help on your journey to wellness:▶️ Subscribe so you will never miss a YouTube video.

The drive will cover all 1.15 crore girls who turn 14 each year and will run as a special programme, separate from India's Universal Immunisation Programme (UIP).  

From Discovery to Delivery: Charting Progress in Gynecologic Oncology, hosted by Ursula A. Matulonis, MD, brings expert insights into the most recent breakthroughs, evolving standards, and emerging therapies across gynecologic cancers. Dr Matulonis is chief of the Division of Gynecologic Oncology and the Brock-Wilcon Family Chair at the Dana-Farber Cancer Institute, as well as a professor of medicine at Harvard Medical School, both in Boston, Massachusetts.In this episode, Dr Matulonis sat down with guest Susana M. Campos, MD, MPH. Dr Campos is the clinical director and director of Educational Initiatives for the of the Division of Gynecologic Oncology at Dana-Farber Cancer Institute, and an institute physician and assistant professor of medicine at Harvard Medical School in Boston, Massachusetts. Drs Matulonis and Campos discussed the evolving landscape of newly diagnosed cervical cancer, from epidemiologic trends to emerging therapeutic strategies.According to 2026 estimates from the American Cancer Society, approximately 13,400 new cases of invasive cervical cancer will be diagnosed in the United States, with roughly 4200 deaths. Although incidence has declined over time due to human papillomavirus (HPV) vaccination and screening efforts, rates have plateaued, and the disease burden remains substantial, particularly among women aged 35 to 64 years. Dr Campos noted that approximately half of cases occur in women younger than 50 years of age, and about 20% are diagnosed in women older than 65 years of age.Dr Campos reviewed common presenting symptoms, including abnormal vaginal bleeding, intermenstrual or postmenopausal bleeding, abnormal discharge, pelvic pain, and, in advanced cases, urinary symptoms or leg swelling. She explained that diagnosis begins with pelvic examination and cervical cytology or HPV testing, followed by colposcopy and biopsy when indicated. Although cervical cancer remains one of the few malignancies that is clinically staged, imaging modalities, such as MRI, CT, and PET scans, are critical to accurately defining disease extent, they underscored. Moreover, the discussion highlighted transformative advances in locally advanced disease. The phase 3 KEYNOTE-A18 trial (NCT04221945) demonstrated improved progression-free and overall survival with the addition of pembrolizumab (Keytruda) to standard chemoradiation, establishing a new standard for high-risk patients, Campos stated. Similarly, the phase 3 INTERLACE trial (NCT01566240) showed that short-course induction chemotherapy with carboplatin and paclitaxel before chemoradiation improved long-term outcomes. Campos forecasted that ongoing studies, including the phase 3 NRG-GY037 trial (NCT07061977), may integrate these approaches and further refine optimal treatment sequencing.Lastly, Drs Matulonis and Campos highlighted the expanding therapeutic arsenal in the recurrent and metastatic setting. Campos noted how antibody-drug conjugates, such as tisotumab vedotin-tftv (Tivdak) and fam-trastuzumab deruxtecan-nxki (Enhertu), have demonstrated meaningful activity, particularly in biomarker-selected populations. Campos added that investigational strategies targeting TROP2, such as sacituzumab govitecan-hziy (Trodelvy), represent additional promising avenues.Despite these advances, both experts emphasized that prevention remains paramount. Widespread uptake of HPV vaccination, including the 9-valent vaccine, as well as adherence to routine cervical screening, are essential to reducing the long-term burden of this largely preventable disease.

Robach and Holmes cover the latest news headlines and entertainment updates and give perspective on current events in their daily “Morning Run.”See omnystudio.com/listener for privacy information.

Robach and Holmes cover the latest news headlines and entertainment updates and give perspective on current events in their daily “Morning Run.”See omnystudio.com/listener for privacy information.

Robach and Holmes cover the latest news headlines and entertainment updates and give perspective on current events in their daily “Morning Run.”See omnystudio.com/listener for privacy information.

Robach and Holmes cover the latest news headlines and entertainment updates and give perspective on current events in their daily “Morning Run.”See omnystudio.com/listener for privacy information.

What does a pap smear test for, and what happens after an abnormal pap smear? In this episode of SHE MD, Mary Alice Haney interviews Dr. Thaïs Aliabadi to break down exactly what a pap smear is, how HPV affects cervical cancer risk, and what women need to know about abnormal results. A pap smear is a cervical cancer screening test that checks for precancerous and cancerous cells on the cervix. A pap smear does not test for ovarian cancer, uterine conditions, or all sexually transmitted infections. HPV testing is often performed at the same time because high risk HPV is the leading cause of cervical cancer.Can you have HPV with a normal Pap smear? What actually happens after an abnormal result? Dr. A answers these questions and more, explaining that while most HPV infections clear on their own within one to two years, monitoring and follow-up are key. The bottom line: cervical cancer is highly preventable with routine Pap and HPV screening—but annual well-woman visits are still essential for protecting your long-term health.Subscribe to SHE MD Podcast for expert tips on PCOS, Endometriosis, fertility, and hormonal balance. Share with friends and visit SHE MD website and Ovii for research-backed resources, holistic health strategies, and expert guidance on women's health and well-being.Sponsors:Premier Protein: Find your favorite flavor at PremierProtein.com or at Amazon, Walmart, and other major retailers.Midi Health - Ready to feel your best and write your second act script? Visit JoinMidi.com today to book your personalized, insurance-covered virtual visit. Bobbie: If you want to feed with confidence too, head to hibobbie.com — to the formula trusted by parents and loved by their babies — 700k and counting.Peloton - Let yourself run, lift, sculpt, push, and go. Explore the new Peloton Cross Training Tread+ at onepeloton.com What You'll Learn:What a pap smear actually tests for and what it does not screenHow HPV and pap smear testing work together to prevent cervical cancerWhat abnormal pap smear results like ASCUS, CIN1, CIN2, and CIN3 meanWhen a normal pap smear still requires follow up or colposcopyWhy regular pap smear screening makes cervical cancer almost entirely preventableKey Timestamps:00:00 Introduction02:00 What a pap smear tests for and what it does not check03:40 HPV explained: low risk vs high risk and why it's common05:15 Screening guidelines and why pap smear alone is not enough07:15 What types of results you can get back from a pap smear 17:20 When you need a colposcopy and what happens during the procedure22:15 Biopsy results and CIN staging explained34:00 Treatment options: cryotherapy, LEEP procedure, and cold knife cone35:40 Risks of aggressive LEEP and pregnancy considerations38:00 HPV dormancy and common misconceptions41:45 HPV vaccine recommendations and prevention43:00 Final takeaway: pap smear schedule vs well woman examKey Takeaways:A pap smear screens for cervical cancer and HPV, not STDs, ovarian cancer, or uterine conditionsHigh risk HPV, especially types 16 and 18, may require colposcopy even with a normal pap smearColposcopy and cervical biopsy confirm whether precancer cells are present and guide treatmentMost HPV infections clear naturally within one to two yearsCervical cancer is preventable with routine pap smear and HPV screening, but annual well woman exams remain essentialResources Mentioned in This Episode:

Featuring perspectives from Dr Terence Friedlander and Dr Rana R McKay, including the following topics: Introduction (0:00) Up-Front Treatment of Ovarian Cancer (OC) (1:13) Management of Platinum-Resistant OC (11:49) Up-Front Management of Metastatic Endometrial Cancer (32:42) Management of HER2-Positive Gynecologic Cancers (45:11) Management of Cervical Cancer (53:10) CME information and select publications

(00:00:00) Author Linda Gottfried joins us to share insights from her new book How to Live Your Life Like You’ve Already Won the Lottery, a guide to shifting perspective, embracing abundance, and finding purpose beyond financial luck. She invites readers to rethink what it means to “win” and to cultivate joy in everyday life. (00:16:00) Then, with a grateful heart, Dan Tomaso returns to walk us through last week’s powerful winter storm — what drove its intensity, how it compares to past systems, and what Pennsylvanians can expect for the rest of the season. (00:27:29) Finally, Dr. Josh Kesterson helps us mark Cervical Cancer Awareness Month with essential, empowering information. We discuss what cervical cancer is, the symptoms women should watch for, why HPV vaccination and regular screening remain the strongest tools for prevention, and how advances in imaging, treatment, and mobile health services are expanding access. Dr. Kesterson also outlines the resources available through UPMC Hillman Cancer Center and UPMC Magee‑Women for women who may face barriers to care. Support WITF: https://www.witf.org/support/give-now/See omnystudio.com/listener for privacy information.

New research which has just been published in the British Medical Journal, suggests that testing menstrual blood for signs of cervical cancer could be an accurate way of screening for the disease. The BBC's Health Correspondent, Sophie Hutchinson, and Fiona Osgun, Head of Health information at Cancer Research UK join Anita Rani to talk about this new area of research and discuss the options currently open to women. English actor Imogen Poots is back on our screens taking on a challenging role in Kristen Stewart's first feature film, The Chronology of Water. It's a creative adaptation of an acclaimed memoir by American writer Lidia Yuknavitch which centres on her coming to terms with being abused as a child, battling pain and loss, and her ongoing healing journey. Imogen Poots joins Anita in the studio.The Kurdish-led self-administration in the north east of Syria is a territory where for years women have sat at the centre of political life, security and decision-making. But many are worried that the system is now under pressure following a new agreement between Kurdish authorities and the Syrian government, which will integrate the region into the Syrian state being rebuilt after the toppling of Bashar al-Assad in 2024. Anita is joined by Lina Shaikhouni, journalist at the BBC World Service and Dilar Dirik, Kurdish writer and author of The Kurdish Women's Movement: History, Theory, Practice.Paula Varjack talks to Anita about her show Nine Sixteenths. It examines the fallout from the infamous Janet Jackson and Justin Timberlake ‘wardrobe malfunction' incident at the 2004 Superbowl and the backlash that almost ruined Jackson's career. The play questions what this says about the demographics of who controls the media, the scrutinising of black women in the public eye and asks if anything has changed?Presenter: Anita Rani Producer : Corinna Jones

Kenya's national action plan to eliminate cervical cancer by 2030 offers renewed hope for girls and women in rural communities, where access to prevention and care has often been limited. Aligned with World Health Organization (WHO)'s targets, the plan focuses on free vaccines to prevent human papillomavirus (HPV) infection – which can lead to various cancers including cervical cancer – providing early screening and timely treatment.Joseph Mogga with WHO's office in Nairobi, spoke to UN News's Assumpta Massoi and explained how by bringing services closer to where women live, Kenya is signalling a strong, positive commitment to ensure that no girl or woman is left behind – especially when it comes to cervical cancer prevention.

Cervical cancer continues to disproportionately impact African American women — and many don't find out until it's advanced.   On Table Talk Tuesday, we're having a real, necessary conversation about cervical cancer, the risks, the warning signs, and why awareness, early detection, and advocacy can save lives.   This is about education. This is about empowerment. This is about protecting our health and our future.   If you are a woman over 40, this conversation is for you.

January is marked worldwide as cervical cancer awareness month. According to the World Health Organisation, cervical cancer is one of the most preventable types of cancer, yet it kills over 350,000 women globally every year. We look at how Kenya, where more than half of those diagnosed die within a year, is approaching the disease; and how Botswana manages to keep prevalence low. Also, weddings are a big deal in Nigeria, but what options do couples have when that dream wedding is just too expensive?Presenter: Nkechi Ogbonna Producers: Keikantse Shumba, Blessing Aderogba and Chiamaka Dike Technical Producer: Maxwell Onyango Senior Producer: Charles Gitonga Editors: Samuel Murunga and Maryam Abdalla

As part of Cervical Cancer Awareness Week 2026 in Israel, the Israel Cancer Association emphasized that increasing awareness, vaccination, and early detection can significantly reduce cervical cancer rates in Israel—similar to Australia—and may even lead to its elimination altogether. Self-HPV testing kits can have an important role in this effort. Dr. Inbar Bandach, Deputy CEO and Lab Manager at Medica Diagnostics spoke to KAN's Naomi Segal. (Photo: Courtesy) See omnystudio.com/listener for privacy information.

More than 25 years ago, photojournalist Kate Geraghty travelled to Timor-Leste to document the struggles of the Timorese people as they wrestled back their independence from a decades-long, and often brutal, Indonesian occupation. Last year, Geraghty returned to Timor-Leste, with health editor Kate Aubusson, where they witnessed a devastating legacy of this struggle: a deep, cultural tradition of withstanding pain.Coupled with a shame about cancer, and a lack of resources, a diagnosis of cervical cancer often equals a death sentence in Timor-Leste. And this in a place only 85 minutes away by plane from Australia, which is on track to become the first country in the world to eliminate the cancer by 2035. Today, Kate Geraghty and Kate Aubusson, on the Australian and Timorese medicos, who are helping the women of Timor-Leste fight this entirely preventable cancer.Subscribe to The Age & SMH: https://subscribe.smh.com.au/See omnystudio.com/listener for privacy information.

More than 25 years ago, photojournalist Kate Geraghty travelled to Timor-Leste to document the struggles of the Timorese people as they wrestled back their independence from a decades-long, and often brutal, Indonesian occupation. Last year, Geraghty returned to Timor-Leste, with health editor Kate Aubusson, where they witnessed a devastating legacy of this struggle: a deep, cultural tradition of withstanding pain.Coupled with a shame about cancer, and a lack of resources, a diagnosis of cervical cancer often equals a death sentence in Timor-Leste. And this in a place only 85 minutes away by plane from Australia, which is on track to become the first country in the world to eliminate the cancer by 2035. Today, Kate Geraghty and Kate Aubusson, on the Australian and Timorese medicos, who are helping the women of Timor-Leste fight this entirely preventable cancer.Subscribe to The Age & SMH: https://subscribe.smh.com.au/See omnystudio.com/listener for privacy information.

Women may now choose to collect their own samples to test for human papilloma virus, or HPV as part of their screening regimen for cervical cancer, the American Cancer Society now says. Kimmel Cancer Center director William Nelson at Johns … Since most cervical cancer is caused by infection with a virus, when should screening start? Elizabeth Tracey reports Read More »

New research is transforming the outlook for cervical and uterine cancers -- two of the most serious gynecologic malignancies worldwide – and we'll be hearing from one of the people shaping that progress, Dr. Mary McCormack, on this episode of Raise the Line. From her perch as the senior clinical oncologist for gynecological cancer at University College London Hospitals, Dr. McCormack has been a driving force in clinical research in the field, most notably as leader of the influential INTERLACE study, which changed global practice in the treatment of locally advanced cervical cancer, a key reason she was named to Time Magazine's 2025 list of the 100 most influential people in health. “In general, the protocol has been well received and it was adopted into the National Comprehensive Cancer Network guidelines which is a really big deal because lots of centers, particularly in South and Central America and Southeast Asia, follow the NCCN's lead.”In this conversation with host Michael Carrese, you'll learn about how Dr. McCormack overcame recruitment and funding challenges, the need for greater access to and affordability of treatments, and what lies ahead for women's cancer treatment worldwide. Mentioned in this episode:INTERLACE Cervical Cancer Trial If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Doctors have long recommended regular cervical cancer screenings. Traditionally doctors perform these exams using a speculum, which often say is uncomfortable and, for many, quite painful. Some recent developments could make a large number of these screenings easier. In early January, the Health Resources and Services Administration, which is part of the Department of Health and Human Services, updated its guidelines to say that self-administered tests are an acceptable way to screen for human papillomavirus. HPV is a sexually-transmitted disease that causes the majority of cervical cancer cases. OB-GYNs are hopeful that at-home testing will make cervical cancer screenings easier to access…. and significantly more comfortable. Guests: Dr. Linda Eckert, professor of Obstetrics and Gynecology at the University of Washington School of Medicine Related links: New Guidelines Endorse Self-Swab Alternative to Pap Smear for Cervical Cancer Testing - The New York Times Cervical Cancer Risk Factors | Cervical Cancer | CDC The FDA has approved an at-home HPV test. What you need to know : NPR Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.

Cervical cancer kills almost 350,000 women each year. What's more horrifying, is that millions have died of this disease that's nearly 100% preventable. It's no secret that healthcare is full of inequities, with a severe lack of accessible screening programs. But women's health care is also impeded by cultural, gender, and political barriers, issues that have combined to create devastating consequences.  In Enough: Because We Can Stop Cervical Cancer (Cambridge UP, 2024), Dr Linda Eckert takes her years of experience and weaves it together with the voices of the courageous women who use their own experience of cervical cancer to advocate for change. This heart-breaking, yet hopeful, book takes you through the world of cervical cancer with evidence-based information, personal stories and actionable outcomes. Society flourishes when women have access to safe and affordable healthcare. Together we can make this need a reality and eliminate the world's most preventable cancer. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Cervical cancer kills almost 350,000 women each year. What's more horrifying, is that millions have died of this disease that's nearly 100% preventable. It's no secret that healthcare is full of inequities, with a severe lack of accessible screening programs. But women's health care is also impeded by cultural, gender, and political barriers, issues that have combined to create devastating consequences.  In Enough: Because We Can Stop Cervical Cancer (Cambridge UP, 2024), Dr Linda Eckert takes her years of experience and weaves it together with the voices of the courageous women who use their own experience of cervical cancer to advocate for change. This heart-breaking, yet hopeful, book takes you through the world of cervical cancer with evidence-based information, personal stories and actionable outcomes. Society flourishes when women have access to safe and affordable healthcare. Together we can make this need a reality and eliminate the world's most preventable cancer. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/gender-studies

Cervical cancer kills almost 350,000 women each year. What's more horrifying, is that millions have died of this disease that's nearly 100% preventable. It's no secret that healthcare is full of inequities, with a severe lack of accessible screening programs. But women's health care is also impeded by cultural, gender, and political barriers, issues that have combined to create devastating consequences.  In Enough: Because We Can Stop Cervical Cancer (Cambridge UP, 2024), Dr Linda Eckert takes her years of experience and weaves it together with the voices of the courageous women who use their own experience of cervical cancer to advocate for change. This heart-breaking, yet hopeful, book takes you through the world of cervical cancer with evidence-based information, personal stories and actionable outcomes. Society flourishes when women have access to safe and affordable healthcare. Together we can make this need a reality and eliminate the world's most preventable cancer. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/medicine

Cervical cancer is one of the most preventable cancers, and when caught early, it's often highly curable. In fact, reports say Australia is on track to eliminate cervical cancer by 2035. However, many women still have unanswered questions about symptoms, screening and what a diagnosis really means. In this Baptist HealthTalk episode, host Johanna Gomez sits down with Dr. Ryan Kahn, a gynecologic oncologist with Baptist Health Cancer Care, to answer the most searched questions women have about cervical cancer. They cover why early stages are often symptom-free, the warning signs to watch for, how survival rates change by stage and what treatment can look like (surgery, chemo, radiation and newer targeted therapies). Dr. Kahn also clears up common misconceptions about HPV, the HPV vaccine and how often you actually need a Pap/HPV test. Listen now for clear, practical guidance to help you protect your health.If you're due for screening, or noticing changes, this episode helps you know what to do next.Host:Johanna GomezAward-Winning Host & JournalistGuest:Ryan Kahn, M.D. Gynecologic OncologistBaptist Health Cancer Care

Dr. Aileen Marty, Infectious Disease Specialist and Professor at Florida International University, joins Bob Sirott to talk about the latest health news. Dr. Marty discusses new federal screening guidance pertaining to cervical cancer tests and the increase in flu and measles cases.

Welcome to the Mediumship Sister's Podcast! Season 6, episode 18!Today join the sisters as Ciarra shares Part 3 of her personal healing journey with being diagnosed with Cervical Cancer in May of 2025. Part 3 and the closing episode for her healing journey. Please take a listen to all 3 episodes. Part 3 takes us through Ciarra's last set of recent scans, doctors reactions, shares her mindset, rituals and ways she moved through navigating the allopathic healthcare system with the traditional Cancer approaches in BC Canada. Through the ups and downs, she found a safe haven of healing, connecting in nature, nurturing self in so many ways and all the while trusting her own intuition and connection to Spirit and the belief that healing is not only possible, but happening within. Sharing Ciarra's story will inspire others to believe in their ability to create a space within themselves for healing, for balance and trusting their intuition. To be curious, ask questions and do your own research for ways to heal beyond trusting the traditional system. And this inspiring journey completes our episodes for 2025.Thank you for listening! We are grateful and blessed!Listen to Part 1 of Ciarra's journeyhttps://podcasts.apple.com/us/podcast/the-mediumship-sisters-podcast/id1535520455?i=1000740173959Listen to Part 2 of Ciarra's Journeyhttps://podcasts.apple.com/us/podcast/the-mediumship-sisters-podcast/id1535520455?i=1000741468441resources~Books to consider if you are facing a Cancer diagnosis, as food can be our medicine, these two books helped Ciarra navigate her food choices and understand the links to Cancer."Keto for Cancer" by Miriam Kalamian "The Metabolic Approach to Cancer: Integrating Deep Nutrition, the Ketogenic Diet, and Nontoxic Bio-Individualized Therapies" by Dr. Nasha Winters  and Jess Higgins Kelley MNTitems below can be found on amazon USA and Canada*ESSIAC* all natural herbal liquid extract 300 ml bottle*Tarens T9314-012M Art creations sketchbook /notebook*Natural Factors Glutathione LipoMicel Matrix 300 mg softgels*Natural Factors Liposomal Viatmin C High Absorption 90 liquid softgels 1000mg*SAKURA Koi pocket field sketch watercolor set on the goMEDITATIONS~https://open.spotify.com/episode/1N4WTTy5AIrxmgcU68x3Cd?si=bKaRlA2qRoKB5pi7yneuqAhttps://open.spotify.com/episode/2S5peBb7JqPhn77HyfeyLp?si=TZciaeswR6eOaSrXEI-Dvwhttps://podcasts.apple.com/us/podcast/the-mediumship-sisters-podcast/id1535520455?i=1000724628073Message Ciarra directly if you would like more information and resources.If you enjoy our podcast, please share it with others you think would enjoy it and please leave us a review !Work with us, follow our InstagramFollow us on You tubehttps://www.youtube.com/@MediumshipSistersPodcastFollow us on Instagram @themediumshipsistersCiarra Saylor Douglas@ciarrasaylor_mediumship @ciarrasaylorhttps://www.ciarralovesart.com/shop-1 Mariana Lucker@star.aligned.alchemy www.staralignedalchemy.com Paige Sturgeon@thewildspiritpaige @redhillphotowww.thewildspiritpaige.com www.redhillphotography.comrecorded 12/16/25

Does a USB stick, or a mobile phone, weigh more once it's filled with data? What's the placebo effect, and how does it work? How does the human papilloma virus (HPV) cause disease, and how can the HPV vaccine and male circumcision protect you from cervical cancer and HIV? Does Cape Town face two oceans? Can Brazil nut proteins be present in semen and trigger subsequent anaphylaxis in a sexual partner? And what can we do about post-herpetic neuralgia causes by shingles (VZV)? Like this podcast? Please help us by supporting the Naked Scientists

The benefits of sauna and sunlight during winter monthsApplied Behavioral Analysis in autism treatmentWhat are good supplements to take for HPV virus?

I was diagnosed with follicular lymphoma, but my symptoms may be caused by something else, per my oncologistI've been taking acidophilus and eating yogurt, but still have diarrhea for the last five months since taking a round of antibioticsThe consequences of antibiotic useMy carotid artery intima-media thickness shows higher than normal thickness. Should I be concerned?

Broadcast from KSQD, Santa Cruz on 12-11-2025: Dr. Dawn presents colleague Dr. Paul Godin's essay on why US healthcare fails as a market system . She explains that healthcare violates every assumption of functional markets: patients can't compare options during emergencies, information asymmetry prevents informed decisions, demand is inelastic when one has an urgent medical issue, and trust is essential to medicine and in direct conflict with profit incentives. Since 1988's Knox-Keen Act allowed for-profit healthcare, private equity has acquired and stripped hospitals, while administrative costs consume enormous resources fighting over payments rather than providing care. She contrasts this with European models like Switzerland and Germany where everyone must participate, insurers must accept all patients, and profit on basic coverage is limited. She celebrates a vaccination success story: HPV vaccines have reduced cervical cancer by 50% over 30 years. The American Cancer Society now endorses self-collected vaginal samples for HPV screening, with an FDA-approved at-home kit from Teal Health allowing women to skip speculums and traditional Pap smears. Current guidelines recommend screening starting at age 25, with testing every five years after a negative result. Dr. Dawn issues a health alert about multiple hospitalizations in Santa Cruz County from foraged wild mushrooms identified incorrectly by phone apps. She describes cholinergic toxicity symptoms: sweating, excessive salivation, pinpoint pupils, and abdominal cramping—signs requiring immediate emergency care rather than waiting it out. She offers follow-up vaccine advice: "go in wet, then sweat." Hydrate before vaccination, then take a hot Epsom salt bath until sweat runs off your face. This helps eliminate adjuvants that cause post-vaccine fatigue and aches, which are often misinterpreted as catching illness from the vaccine itself. Dr. Dawn expresses alarm that Kennedy's reconstituted ACIP nearly voted to eliminate hepatitis B vaccination at birth. She notes infants exposed to infected mothers have 99% infection rates, with half becoming chronically infected and half of those developing terminal cirrhosis or cancer. Testing pregnant women misses infections acquired during pregnancy, and 12-16% of delivering women have no test records. Major insurers have committed to covering birth vaccination through 2026 despite the panel's actions. She offers holiday microbiome advice from researcher Karen Corbin: increase fiber intake through steel-cut oats, whole grain breads like Dave's Killer Bread, beans, apples, and alternative pastas made from lentils or garbanzo beans. Cooking potatoes ahead and reheating creates resistant starch that feeds beneficial gut bacteria, reduces inflammation, and even stimulates natural GLP-1 production. Dr. Dawn reviews research proving health insurance saves lives. When the ACA's Medicaid expansion became optional by state, researchers could compare outcomes, finding 8% lower mortality and 19,000 fewer deaths in expansion states over four years. An accidental IRS experiment—sending insurance enrollment letters to only 85% of penalty payers—showed significantly lower mortality among those who subsequently got insured. Studies of gunshot and auto accident victims found uninsured patients died more often despite receiving identical emergency treatment. She concludes with surprising cancer symptoms: chest pain specifically triggered by alcohol consumption may indicate Hodgkin's lymphoma, as vasodilation activates inflammatory chemicals in affected lymph nodes. Fractures from minimal trauma in people without osteoporosis warrant investigation, as 5% of cancers involve bone. Elevated calcium levels double cancer diagnosis risk in the following year and should prompt follow-up testing.